Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intranasal Application of Lactococcus lactis W136 Is Safe in Chronic Rhinosinusitis Patients With Previous Sinus Surgery
Léandra Mfuna Endam, Saud Alromaih, Emmanuel González, et al.
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: A bibliometric analysis and systematic review
Douglas Xavier-Santos, Marina Padilha, Giovanna Alexandre Fabiano, et al.
Trends in Food Science & Technology (2022) Vol. 120, pp. 174-192
Open Access | Times Cited: 97
Epithelial Barrier in the Nasal Mucosa, Related Risk Factors and Diseases
Rong Zhang, Lan Zhang, Peishan Li, et al.
International Archives of Allergy and Immunology (2023) Vol. 184, Iss. 5, pp. 481-501
Open Access | Times Cited: 38
Lactic acid bacteria as probiotics for the nose?
Ilke De Boeck, Irina Spacova, Olivier M. Vanderveken, et al.
Microbial Biotechnology (2021) Vol. 14, Iss. 3, pp. 859-869
Open Access | Times Cited: 43
Unraveling the role of the microbiome in chronic rhinosinusitis
Alkis J. Psaltis, Brett Wagner Mackenzie, Emily K. Cope, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 149, Iss. 5, pp. 1513-1521
Open Access | Times Cited: 28
Immunomodulatory Role of Nutrients: How Can Pulmonary Dysfunctions Improve?
Sarah Cristina Gozzi-Silva, Franciane Mouradian Emidio Teixeira, Alberto José da Silva Duarte, et al.
Frontiers in Nutrition (2021) Vol. 8
Open Access | Times Cited: 40
Immunomodulatory action of Lactococcus lactis
Lejaniya Abdul Kalam Saleena, Michelle Yee Mun Teo, Yu Hsuan How, et al.
Journal of Bioscience and Bioengineering (2022) Vol. 135, Iss. 1, pp. 1-9
Closed Access | Times Cited: 21
Alleviating symptoms of paediatric acute rhinosinusitis and acute otitis media with otorrhea using nasal-spraying Bacillus probiotics: a randomized controlled trial
Thanh Huu Khieu, Dung Phuong Le, Binh T. Nguyen, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Respiratory microbiome and respiratory infections
X. Zou, Yi Mu, Yang Ni, et al.
Chinese Science Bulletin (Chinese Version) (2025) Vol. 70, Iss. 10, pp. 1446-1459
Closed Access
The role of probiotics in modulating the microbiota of the nose and paranasal sinuses and reducing chronic inflammation of the paranasal sinuses
Jakub Zblewski, Bartosz Kozakiewicz, Krzysztof Dalke, et al.
Polski Przegląd Otorynolaryngologiczny (2025) Vol. 14, Iss. 1, pp. 1-6
Closed Access
The Respiratory Tract Microbiome and Human Health
Patricia Fernández de Córdoba‐Ansón, Iván Linares‐Ambohades, Fernando Baquero, et al.
Microbial Biotechnology (2025) Vol. 18, Iss. 5
Open Access
Topical Microbial Therapeutics against Respiratory Viral Infections
Irina Spacova, Ilke De Boeck, Peter A. Bron, et al.
Trends in Molecular Medicine (2021) Vol. 27, Iss. 6, pp. 538-553
Open Access | Times Cited: 25
Positioning the preventive potential of microbiome treatments for cystic fibrosis in the context of current therapies
Eline Cauwenberghs, Ilke De Boeck, Irina Spacova, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 1, pp. 101371-101371
Open Access | Times Cited: 3
Environmental exposures, the oral–lung axis and respiratory health: The airway microbiome goes on stage for the personalized management of human lung function
Junkal Garmendia, Pilar Cebollero‐Rivas
Microbial Biotechnology (2024) Vol. 17, Iss. 6
Open Access | Times Cited: 3
Influence of the Microbiome on Chronic Rhinosinusitis With and Without Polyps: An Evolving Discussion
Kyle Huntley, Joshua Raber, Lauren Fine, et al.
Frontiers in Allergy (2021) Vol. 2
Open Access | Times Cited: 20
Advances in co-pathogenesis of the united airway diseases
Xinjun Xu, Jiali Yin, Yujuan Yang, et al.
Respiratory Medicine (2024) Vol. 225, pp. 107580-107580
Closed Access | Times Cited: 2
Effects of Probiotic Supplementation during Chronic Rhinosinusitis on the Microbiome
Arkadiusz Standyło, Aleksandra Obuchowska, Anna Horaczyńska-Wojtaś, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 6, pp. 1726-1726
Open Access | Times Cited: 1
Update on the Role of the Microbiome in Chronic Rhinosinusitis
Jakob L. Fischer, Jivianne T. Lee
Current Treatment Options in Allergy (2024) Vol. 11, Iss. 2, pp. 17-33
Open Access | Times Cited: 1
The role of airways microbiota on local and systemic diseases: a rationale for probiotics delivery to the respiratory tract
Stefania Glieca, Eride Quarta, Benedetta Bottari, et al.
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 7, pp. 991-1005
Open Access | Times Cited: 1
The Role of the Gut and Airway Microbiota in Chronic Rhinosinusitis with Nasal Polyps: A Systematic Review
Manuel Gómez‐García, Emma Moreno-Jiménez, Natalia Morgado, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8223-8223
Open Access | Times Cited: 1
Immunological mechanisms and treatable traits of chronic rhinosinusitis in Asia: A narrative review
Yin Yao, Hongyu Zhu, Ming Zeng, et al.
Clinical Otolaryngology (2022) Vol. 48, Iss. 2, pp. 363-370
Closed Access | Times Cited: 7
Interactions of the bacteriome, virome, and immune system in the nose
Matthew Flynn, Zinnia Lyall, Gwendolyn Shepherd, et al.
FEMS Microbes (2022) Vol. 3
Open Access | Times Cited: 6
Review: The Nose as a Route for Therapy. Part 2 Immunotherapy
Y Padayachee, Sabine Flicker, Sophia Linton, et al.
Frontiers in Allergy (2021) Vol. 2
Open Access | Times Cited: 8
Efficacy and safety of Oral LL‐37 against the Omicron BA.5.1.3 variant of SARS‐COV‐2: A randomized trial
Yiming Zhao, Hanlin Zhang, Zhizhuang Joe Zhao, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 8
Open Access | Times Cited: 3
Response to intranasal Lactococcus lactis W136 probiotic supplementation in refractory CRS is associated with modulation of non-type 2 inflammation and epithelial regeneration
Saud Alromaih, Oumkaltoum Harati, Leandra Endam Mfuna, et al.
Frontiers in Allergy (2023) Vol. 4
Open Access | Times Cited: 2
Role of probiotics in chronic rhinosinusitis: a systematic review of randomised, controlled trials
Pei Yuan Fong, Kaiser G. Lim, A. Gnanam, et al.
The Journal of Laryngology & Otology (2023) Vol. 137, Iss. 12, pp. 1300-1311
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top